ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 263

Health Professionals Agreed with Recommendations to Evaluate and Optimize Adherence to Disease-modifying Treatments, but Perceived Feasibility Was Lower: A Study of 357 Physicians and Health Professionals in France

Laure Gossec1, Anna Moltó 2, Catherine Beauvais 3, Eric Senbel 4, René-Marc Flipo 5, Sophie Pouplin 6, Christophe Richez 7, Alain Saraux 8, Philippe Gaudin 9, Daniel WENDLING 10 and Maxime Dougados 11, 1Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France, 2Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, 3Paris St Antoine University Hospital, Paris, France, 4Rheumtologist Private Practice, Marseille, France, 5University of Lille, CHU Lille, department of rheumatology, 59,000 Lille, France, Lille, France, 6Rouen University Hospital, Rouen, France, 7Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France, 8CHU de la Cavale-Blanche Brest, Brest, France, 9Rheumatology Department, CHU Grenoble Alpes Hôpital Sud and GREPI - Université Grenoble Alpes, EA7408, Grenoble - Echirolles, France, 10Rheumatology, University Teaching Hospital (CHRU), Besançon, France, 11Cochin Hospital, Paris, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Clinical practice guidelines, Compliance, rheumatoid arthritis (RA) and axial spondyloarthritis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 10, 2019

Session Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In chronic inflammatory rheumatic diseases (CIRDs), including rheumatoid arthritis, spondyloarthritis, connective tissue diseases and crystal-induced arthritis, long-term adherence to disease-modifying drugs (DMARDs) is only moderate. In 2017, a group of 105 experts developed recommendations to facilitate the evaluation and management of non-adherence to DMARDs in daily practice [1]. Five overarching principles and 10 recommendations were developed [1].

The objective of this study was to evaluate the agreement of French rheumatologists and health professionals (HPs) with these recommendations, their perceived feasibility/ ease of application and participants’ characteristics linked to perceived feasibility.

Methods: Face-to-face meetings were organized across France in 2018 by the program sponsor (Abbvie) with the support of the program committee. During these meetings, the key data and the recommendations were presented and discussed [1]. Participants then informed on paper, their personal data, agreement (from 1 to 5, where 5 is highest) and perceived feasibility (1-5) for each recommendation. Mean agreement and perceived feasibility were calculated for each recommendation. A univariate and multivariate logistic regression identified the characteristics of the participants who rated feasibility the highest (pooled mean above the median).

Results: A total of 38 meetings were held involving 377 physicians/other HPs: 357 (95%) provided analyzable data. The respondents had an average age of 46 years [standard deviation, SD 13]; 223 (63%) were female. Among the 247 (69%) rheumatologists, one third were hospital based (N=90, 37%). Other HPs were nurses (N=81, 23%) or pharmacists (N=14, 4%). Pooled agreement with the overarching principles was very high (mean 4.4 [0.5]). Agreement with the 10 recommendations was also high: pooled mean 4.3 [0.4]; the recommendation with the lowest agreement (mean 3.9 [0.9]) was recommendation 3 on assessing adherence by complex methods. Perceived feasibility was lower (pooled mean 3.4 [0.5]) with a range of means from 2.8 [0.9] (recommendation 3) to 3.9 [0.9] (recommendation 2: assess adherence by an open-ended question). More than 30% of participants rated the feasibility as low (score 1 or 2) for recommendations 3 and 8 (specific intervention in case of non-adherence). The only factor correlated with greater perceived feasibility was being a HP other than a rheumatologist: odds ratio 2.52 [95% confidence interval 1.23-5.15], while age, gender and type of exercise were not significant. Thus, perceived feasibility seemed higher among non-physician HPs, which may be due to the selection of HPs with a strong interest on patient education.

Conclusion: French HPs are in agreement with recently-published recommendations for the evaluation and optimization of adherence to DMARDs [1]. However, feasibility was lower, especially with regard to complex evaluation of non-adherence, and targeted interventions. This initiative has contributed to the dissemination of the recommendations; the next step will be their implementation.

[1] L. Gossec et al. Joint Bone Spine. 2019;86(1):13-19.


Disclosure: L. Gossec, Abbvie, 5, AbbVie, 5, Abbvie, Biogen, BMS, Celgene, Lilly, Novartis, Pfizer, SAnofi-Aventis, UCB, 5, Amgen, 5, Biogen, 5, BMS, 2, 5, Celgene, 5, Celgene Corporation, 2, Janssen, 5, Lilly, 2, 5, MSD, 5, Nordic Pharma, 5, Novartis, 5, Pfizer, 2, 5, Sanofi, 5, Sanofi-Aventis, 5, UCB, 5; A. Moltó, None; C. Beauvais, None; E. Senbel, None; R. Flipo, Janssen, 8, Novartis, 8; S. Pouplin, None; C. Richez, astrazeneca, 5, 8, BMS, 5, 8, Glenmark, 5, 8, Janssen, 5, 8, Lilly, 5, 8, Pfizer, 5, 8, Roche, 5, 8, UCB, 5, 8; A. Saraux, None; P. Gaudin, None; D. WENDLING, None; M. Dougados, AbbVie, 2, 5, 8, Amgen, 5, Biogen, 5, BMS, 2, 5, 8, Eli Lilly, 2, 5, 8, Gilead, 2, 5, Janssen, 2, 5, Merck, 2, 5, Merck Inc, 2, 5, Novartis, 2, 5, 8, Pfizer, 2, 5, 8, Pfizer Inc, 2, 5, Roche, 2, 5, 8, UCB, 2, 5, 8.

To cite this abstract in AMA style:

Gossec L, Moltó A, Beauvais C, Senbel E, Flipo R, Pouplin S, Richez C, Saraux A, Gaudin P, WENDLING D, Dougados M. Health Professionals Agreed with Recommendations to Evaluate and Optimize Adherence to Disease-modifying Treatments, but Perceived Feasibility Was Lower: A Study of 357 Physicians and Health Professionals in France [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/health-professionals-agreed-with-recommendations-to-evaluate-and-optimize-adherence-to-disease-modifying-treatments-but-perceived-feasibility-was-lower-a-study-of-357-physicians-and-health-professio/. Accessed April 17, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-professionals-agreed-with-recommendations-to-evaluate-and-optimize-adherence-to-disease-modifying-treatments-but-perceived-feasibility-was-lower-a-study-of-357-physicians-and-health-professio/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.